Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.3% Passive Stake in UFP Industries
BlackRock, Inc. has reported a 12.3% beneficial ownership stake in UFP Industries Inc. common stock as of March 31, 2025, held for passive investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Quaker Chemical Corp, Disclosing 11.5% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 11.5% of Quaker Chemical Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 13.1% Passive Stake in Halozyme Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 13.1% beneficial ownership stake in Halozyme Therapeutics, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in First Bancshares Inc., Disclosing 7.3% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, reporting a 7.3% beneficial ownership stake in First Bancshares Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.4% beneficial ownership stake in World Kinect Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.0% beneficial ownership stake in Tennant Co's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Discloses 15.3% Passive Stake in Omnicell, Inc.
BlackRock, Inc. has filed an Amendment No. 18 to Schedule 13G, reporting a beneficial ownership of 15.3% in Omnicell, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.9% Stake in Agree Realty Corp.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 10.9% of Agree Realty Corp.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 13.6% of Lumen Technologies, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 11.1% Stake in Eastgroup Properties Inc. via Schedule 13G Amendment
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a beneficial ownership of 11.1% of the Common Stock of Eastgroup Properties Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in Murphy Oil Corp, Discloses 11.7% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 11.7% in Murphy Oil Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.8% beneficial ownership stake in Liberty Energy Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.8% Passive Stake in Privia Health Group
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 12.8% beneficial ownership stake in Privia Health Group, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 10.3% of FirstCash Holdings, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.9% Stake in Insight Enterprises Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 12.9% of Insight Enterprises Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Brandywine Realty Trust, Reports 17.8% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, disclosing its beneficial ownership of 17.8% of Brandywine Realty Trust's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Taylor Morrison Home Corp, Disclosing 13.1% Beneficial Ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, reaffirming its significant beneficial ownership of 13.1% in Taylor Morrison Home Corp's Class A Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 13.7% beneficial ownership stake in Upbound Group, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 13.7% of Cable One, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G, disclosing a 16.2% beneficial ownership stake in Box Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a continued 10.0% beneficial ownership stake in healthcare REIT Healthpeak Properties, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.2% beneficial ownership stake in Provident Financial Services Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 14.9% of Matson, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 14.8% Stake in CSG Systems International
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 14.8% of CSG Systems International Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.2% Stake in Healthcare Services Group
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.2% of Healthcare Services Group Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends EnerSys Stake to 11.8% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 11.8% of EnerSys common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Amends Stake in Owens Corning, Disclosing 10.8% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 11 to Schedule 13G, reporting a 10.8% beneficial ownership stake in Owens Corning's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.8% Passive Stake in Vir Biotechnology
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 10.8% in Vir Biotechnology, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 13.9% Stake in Catalyst Pharmaceuticals
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 13.9% of Catalyst Pharmaceuticals, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 15.2% of Pacira BioSciences, Inc.'s common stock as of March 31, 2025.